58 related articles for article (PubMed ID: 1871716)
1. Cellular localization of activated factor X by Xa-specific probes.
Zacharski LR; Dunwiddie C; Nutt EM; Hunt J; Memoli VA
Thromb Haemost; 1991 May; 65(5):545-8. PubMed ID: 1871716
[TBL] [Abstract][Full Text] [Related]
2. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding.
Zacharski LR; Memoli VA; Morain WD; Schlaeppi JM; Rousseau SM
Thromb Haemost; 1995 May; 73(5):793-7. PubMed ID: 7482405
[TBL] [Abstract][Full Text] [Related]
3. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues.
Werling RW; Zacharski LR; Kisiel W; Bajaj SP; Memoli VA; Rousseau SM
Thromb Haemost; 1993 Apr; 69(4):366-9. PubMed ID: 8497849
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen deposition without thrombin generation in primary human breast cancer tissue.
Costantini V; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM
Cancer Res; 1991 Jan; 51(1):349-53. PubMed ID: 1670992
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
6. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell generation of thrombin via functional prothrombinase assembly.
VanDeWater L; Tracy PB; Aronson D; Mann KG; Dvorak HF
Cancer Res; 1985 Nov; 45(11 Pt 1):5521-5. PubMed ID: 4053025
[TBL] [Abstract][Full Text] [Related]
8. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro.
Donnelly KM; Bromberg ME; Milstone A; Madison McNiff JM; Terwilliger G; Konigsberg WH; Cappello M
Thromb Haemost; 1998 May; 79(5):1041-7. PubMed ID: 9609244
[TBL] [Abstract][Full Text] [Related]
9. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
[TBL] [Abstract][Full Text] [Related]
10. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
Jiang X; Guo YL; Bromberg ME
Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
[TBL] [Abstract][Full Text] [Related]
11. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
[TBL] [Abstract][Full Text] [Related]
12. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
13. Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation.
Borensztajn K; Bijlsma MF; Reitsma PH; Peppelenbosch MP; Spek CA
Thromb Res; 2009 Jun; 124(2):219-25. PubMed ID: 19250659
[TBL] [Abstract][Full Text] [Related]
14. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
15. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
[TBL] [Abstract][Full Text] [Related]
16. Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma.
Wojtukiewicz MZ; Zacharski LR; Ruciñska M; Zimnoch L; Jaromin J; Rózañska-Kudelska M; Kisiel W; Kudryk BJ
Thromb Haemost; 1999 Dec; 82(6):1659-62. PubMed ID: 10613652
[TBL] [Abstract][Full Text] [Related]
17. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells.
Kirszberg C; Rumjanek VM; Monteiro RQ
Thromb Res; 2005; 115(1-2):123-9. PubMed ID: 15567463
[TBL] [Abstract][Full Text] [Related]
18. Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation.
Blanc-Brude OP; Archer F; Leoni P; Derian C; Bolsover S; Laurent GJ; Chambers RC
Exp Cell Res; 2005 Mar; 304(1):16-27. PubMed ID: 15707570
[TBL] [Abstract][Full Text] [Related]
19. Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
Bárdos H; Juhász A; Répássy G; Adány R
Thromb Haemost; 1998 Nov; 80(5):767-72. PubMed ID: 9843169
[TBL] [Abstract][Full Text] [Related]
20. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
